ENTITY

Evaxion Biotech A/S (EVAX US)

7
Analysis
Health CareDenmark
Evaxion Biotech A/S operates as a biotechnology company. The Company develops AI-immunology platform for decoding human immune system to discover and develop immunotherapies for cancer and infectious diseases treatment. Evaxion Biotech serves patients in Denmark.
more
13 Nov 2024 04:03Issuer-paid

EVAX: More Exciting Test Results

EVAX is a clinical stage company that has proprietary AI models designed to more efficiently and more accurately target much-needed...

Share
31 Oct 2024 23:00Issuer-paid

EVAX: Beats Estimates and Highlights Trials

EVAX is a clinical stage company that has proprietary AI models designed to more efficiently and more accurately target much-needed...

Share
04 Oct 2024 01:00Issuer-paid

EVAX: Trial Suggests AI Improves Performance

EVAX is a clinical stage company that has proprietary AI models designed to more efficiently and more accurately target much-needed...

Share
27 Sep 2024 00:00Issuer-paid

EVAX: Expanded Deal with MSD Boosts Prospects

EVAX is a clinical stage company that has proprietary AI models designed to more efficiently and more accurately target much-needed...

Share
09 Sep 2024 23:00Issuer-paid

EVAX: Positive Test Data for Two Treatments

EVAX is a clinical stage company that has proprietary AI models designed to more efficiently and more accurately target much-needed...

Share
x